Multiple Sclerosis (MS) is a neurological disease that affects the central nervous system
(CNS). The diagnosis of the disease is quite challenging due to its variation among patients …

Autoimmunity is a disease that occurs when the body tissue is attacked by its own immune
system. Multiple sclerosis (MS) is an autoimmune illness which triggers neurological …

Over the past 30 years, the world of pharmaceutical toxicology has seen an explosion in the
area of cytokines. An overview of the many aspects of cytokine safety evaluation currently in …

Multiple sclerosis (MS) is described as an immune disorder with inflammation and
neurodegeneration. Relapsing–remitting MS (RRMS) is one of the most common types of …

We have previously shown that immunodominant MBP peptides encapsulated in
mannosylated liposomes (Xemys) effectively suppressed experimental allergic …

Multiple sclerosis (MS) is a heterogeneous chronic immune-mediated disorder of the central
nervous system (CNS) with several environmental and genetic factors participating in its …

We developed an ELISA assay demonstrating the high prevalence of serum IgM to
phosphatidylcholine (IgM-PC) in the first stages of multiple sclerosis (MS). We aimed to …

Background The process for obtaining monoclonal antibodies against a specific antigen is
very laborious, involves sophisticated technologies and it is not available in most research …

Interferon (IFN)‐β is one of the disease modifying drugs used in the treatment of multiple
sclerosis. A predictive marker that indicates good or poor response to the treatment is highly …

Cytokines of different types play an important role in multiple sclerosis (MS) pathogenesis as
mediators and regulators of the immune processes in the central nervous system. The aim of …